CONTACT
SEARCH
SHOP
Our Applications

Applications and Beyond

 

Driving Innovation in Biotechnology: PAN-Biotech’s Applications and Beyond

Cell & Gene Therapy

PAN-Biotech is at the forefront of the rapidly evolving field of cell and gene therapy, providing essential products and services to support groundbreaking research and clinical applications.

  • Cell Therapy: Our cell culture media and supplements are designed to enhance the growth and viability of cells used in cell therapy applications, ensuring optimal performance and therapeutic efficacy.
  • Gene Therapy: We offer specialized reagents and media formulations that facilitate the delivery and expression of therapeutic genes, supporting the development of innovative gene therapies for a range of diseases.
  • Custom Solutions: PAN-Biotech collaborates with researchers and industry partners to develop custom solutions tailored to specific cell and gene therapy applications, ensuring the highest levels of quality and performance.
  • Regulatory Compliance: Our products meet stringent regulatory standards, providing researchers with the confidence needed to advance their therapies through clinical trials and toward commercialization.
    • Proven Cell Culture Media:
      • Immune Cells: Panserin 701, Pancell T, Panserin 413, Lymphopan, ErythroPlus
      • Stem Cells: Endopan, Mesenpan, Neuropan
      • Mesenchymal Stem Cells: PowerStem MSC1, Endopan

Vaccine Production

PAN-Biotech plays a critical role in vaccine production, offering specialized products and expertise that enhance vaccine development and manufacturing processes.

  • Viral Culture Media: Our high-quality media formulations support the propagation and stabilization of viral cultures, ensuring the production of safe and effective vaccines.
  • Process Optimization: PAN-Biotech works closely with vaccine developers to optimize production processes, enhancing yield and consistency while reducing costs and time to market.
  • Rapid Response: In response to emerging infectious diseases, we offer rapid development and scale-up of vaccine production solutions, enabling quick and effective responses to public health challenges.
    • Proven Cell Culture Media:
      • Vero Cells: Panserin ProVero
      • MDCK Cells: Serum-free Medium for MDCK
      • BHK21 Cells: EMEM Fibroblast, Panserin 401
      • Sf9 Cells: Spodopan, Schneider’s Drosophila

Therapeutic Proteins

As a key player in the production of therapeutic proteins, PAN-Biotech offers a comprehensive range of products and services that support the development and manufacture of biologics.

  • Protein Expression: Our cell culture media and supplements are optimized for high-yield protein expression, ensuring the production of therapeutic proteins with consistent quality and activity.
  • Purification and Formulation: We provide reagents and technologies for the purification and formulation of therapeutic proteins, enabling efficient downstream processing and product stabilization.
  • Custom Manufacturing: PAN-Biotech offers custom manufacturing services for therapeutic proteins, tailored to meet the specific requirements of each client and application.
  • Collaborative Development: We partner with pharmaceutical companies and research institutions to develop innovative protein therapeutics, leveraging our expertise and resources to drive advancements in treatment.
    • Proven Cell Culture Media:
      • CHO Cells: Pancell CHO Kit, Pancell CHO-K1 Kit, Panserin C6000, Panserin 411
      • Insect Cells: Spodopan, Grace’s Insect Medium, Schneider’s Drosophila
      • Hybridoma Cells: HybridBoost, ISF-1, Panserin H4000, Panserin H8000, Panserin 413
      • HEK293 Cells: Panserin 293S, Panserin 293A, Panserin 401

mRNA Technology

PAN-Biotech is a leader in the emerging field of mRNA technology, providing solutions that support the development and production of mRNA-based therapies and vaccines.

  • mRNA Synthesis: We offer high-quality reagents that facilitate the synthesis and modification of mRNA molecules, ensuring the production of stable and effective mRNA therapies.
  • Process Development: PAN-Biotech collaborates with researchers and industry leaders to optimize mRNA production processes, ensuring scalability and consistency in large-scale manufacturing.
  • Cutting-Edge Research: We are committed to advancing mRNA technology through ongoing research and innovation, driving the development of new therapies for a wide range of diseases.
    • Proven Cell Culture Media:
      • HEK293 Cells: Panserin 293S, Panserin 293A, Panserin 401